effects of a short therpay of zolpidem with support servo-ventilation versus placebo in patients with central sleep apnea with chronic heart failure

Phase 1

• Conditions: MedDRA version: 18.1Level: PTClassification code 10040979Term: Sleep apnoea syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders; MedDRA version: 18.1Level: LLTClassification code 10019276Term: Heart disease, unspecifiedSystem Organ Class: 100000004849; chronic heart failure and central sleep apnea; Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]

• Registration Number: EUCTR2015-003119-39-FR
• Lead Sponsor: Centre Hospitalier Universitaire de Grenoble

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02-25
• Last Update Posted: 2 October 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

please report to the french version
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 18

Exclusion Criteria

please report to the french version

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: please report to the french version;Secondary Objective: please report to the french version;Primary end point(s): please report to the french version;Timepoint(s) of evaluation of this end point: please report to the french version

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): please report to the french version;Timepoint(s) of evaluation of this end point: please report to the french version